Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
11:40:46 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 57.60 EUR | -2.46% |
|
-2.37% | -9.29% |
| 10-05 | Spanish stocks - Factors to watch on Oct 5 | RE |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.95B 3.3B 2.73B 2.49B 4.69B 314B 4.77B 32.87B 12.86B 164B 12.4B 12.14B 522B | P/E 2026 * |
19.4x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.94B 3.29B 2.72B 2.48B 4.67B 313B 4.76B 32.78B 12.82B 163B 12.36B 12.1B 521B | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 3.23x |
| Free-Float |
31.63% | Yield 2026 * |
1.66% | Yield 2027 * | 1.97% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
Tradegate
| 41L | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -2.46% | ||
| 1 week | -2.37% | ||
| Current month | -2.04% | ||
| 1 month | +0.52% | ||
| 3 months | +7.36% | ||
| 6 months | -32.12% | ||
| Current year | -9.29% |
| 1 week | 57.2 |  | 59.7 |
| 1 month | 56.55 | | 60.7 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 4/13/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 3/15/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.46% | -2.37% | -1.45% | +8.27% | 3.36B | |
| +3.55% | +5.29% | +54.07% | +105.45% | 1,077B | |
| -0.25% | -2.00% | +32.71% | +61.48% | 612B | |
| +0.59% | +4.44% | +23.69% | +91.54% | 501B | |
| -1.48% | +1.68% | +71.42% | +39.59% | 364B | |
| +2.37% | +5.47% | +32.67% | +48.87% | 353B | |
| +2.64% | +4.90% | +21.01% | +43.85% | 278B | |
| +3.24% | +4.25% | -0.31% | +15.71% | 251B | |
| +1.86% | +5.07% | +47.70% | +52.77% | 230B | |
| +2.49% | +7.16% | +32.82% | +102.67% | 190B | |
| Average | +1.22% | +1.78% | +31.43% | +57.02% | 385.99B | |
| Weighted average by Cap. | +1.01% | +1.58% | +39.03% | +71.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 773M 866M 717M 653M 1.23B 82.37B 1.25B 8.62B 3.37B 42.91B 3.25B 3.18B 137B | 888M 995M 823M 750M 1.41B 94.66B 1.44B 9.91B 3.88B 49.31B 3.74B 3.66B 157B |
| Net income | 146M 164M 136M 124M 233M 15.59B 237M 1.63B 638M 8.12B 615M 602M 25.92B | 169M 189M 156M 142M 268M 17.98B 273M 1.88B 736M 9.37B 710M 695M 29.9B |
| Net Debt | -8.25M -9.25M -7.65M -6.97M -13.12M -879M -13.36M -92.04M -36.01M -458M -34.72M -33.98M -1.46B | -74.59M -83.63M -69.18M -63.01M -119M -7.95B -121M -832M -326M -4.14B -314M -307M -13.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | €57.60 | -2.46% | 146,481 |
| 26-10-14 | €59.05 | +2.79% | 63,017 |
| 26-10-13 | €57.45 | -1.79% | 72,375 |
| 26-10-12 | €58.50 | +0.78% | 62,910 |
| 26-10-09 | €58.05 | -0.17% | 56,180 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
